Kaplan Andrew T. — SEC Form 4 filings
SEC reporting owner CIK 1752059. 1 Form 4 filing on record with FilingPulse; latest filed 2026-04-20.
Transaction summary — filings shown
Covers all 1 filing on record, filed 2026-04-20 to 2026-04-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 8,398,438 shares, $134,375,008 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 3.
- Largest priced transaction: purchase of 8,398,438 shares @ $16.00 ($134,375,008) in Kailera Therapeutics, Inc., filed 2026-04-20.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Kailera Therapeutics, Inc. (KLRA) | Director, 10% owner | 1 | 1 leg · 8,398,438 sh · $134,375,008 | — | 3 |
Form 4 filings — Kaplan Andrew T.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-04-20 | 4 | Kailera Therapeutics, Inc. (KLRA) | Conversion (C): 17,857,143 · Purchase (P): 8,398,438 @ $16 · Conversion (C): 17,857,143 (derivative) @ $0 · Grant/award (A): 38,300 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1752059 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →